VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ACTG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ACTGAcacia Research Corporation
$4.25$411M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksACTGCash Flow

Acacia Research Corporation (ACTG) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow is entirely episodic, with quarterly FCF margins ranging from -48.2% to 93.5%, demonstrating that cash generation is decoupled from operational profitability and is instead driven by lumpy settlement receipts.

Income StatementBalance SheetCash FlowRatios

ACTG Cash Flow Statement

Annual statement

ACTG Cash Flow Statement

Acacia Research Corporation (ACTG) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations35.43M75.24M50.12M-22.51M-37.34M13.33M-19.62M-2.31M20.88M24.48M34.06M-9.95M4.18M-3.51M104.95M59.11M44.92M16.12M2.6M-2.62M6.36M-2.99M-3.96M-3.91M-4.42M-12.56M-34.69M-6.13M-3.56M-1.71M-1.53M
Operating CF Margin %-26.38%40.98%-17.99%-63.04%15.14%-65.88%-20.52%15.88%37.43%22.31%-7.96%3.2%-2.69%41.86%34.32%34.08%23.94%5.39%-4.97%18.26%-15.28%-92.41%-565.03%-10288.37%-50.99%-60866.67%-5028.69%-931.68%-395.92%-47.16%
Operating CF Growth %169.9%50.12%322.71%39.72%-380.17%167.92%-750.09%-111.06%-14.71%-28.13%442.36%-337.79%219.24%-103.34%77.55%31.58%178.71%519.92%199.39%-141.14%312.68%24.48%-1.25%11.62%64.78%63.79%-465.51%-72.38%-108.19%-11.87%-178.73%
Net Income-17.84M21.68M-34.7M63.15M-110.94M150.37M113.44M-17.13M-104.85M21.68M-54.8M-157.48M-66.66M-58.84M59.29M20.28M37.02M-5.63M-13.76M-15.45M-5.5M-6.28M-5.44M-18.97M-12.55M-22.27M-29.16M-8.2M-6.19M-2.86M426.42K
Depreciation & Amortization32.03M43.35M33.57M14.73M13.51M10.69M4.8M3.23M27.14M22.24M34.35M53.29M57.55M53.89M39.17M9.85M7.02M4.76M6.17M5.7M5.39M4.98M551K2.41M1.8M3.87M2.66M1.82M1.71M529.26K22.41K
Stock-Based Compensation4.35M5.74M4.79M3.3M3.82M2.05M1.66M1.07M-317K8.88M9.06M11.05M18.11M27.89M25.66M13.58M7.12M7.07M7.36M03.95M197K000000000
Deferred Taxes-5.9M4.84M-6.05M-3.66M-17.81M-167.53M-136.89M0106.41M-44.61M42.34M104.88M-1.74M-25.08M6.55M0-32K-7.04M488K0-36K-143K-143K-136K-142K-182K-81K00-193.23K245.32K
Other Non-Cash Items36.59M-508K4.52M-27.95M86.16M110K2.84M-1.23M564K-3.04M-477K-109K-28K370K-9.42M-15K-1.51M7.07M6K6.56M465K-119K951K1.65M6.1M-1.81M-8.12M-711K907K817.04K-1.69M
Working Capital Changes-4.46M143K47.98M-72.07M-12.08M17.64M-5.48M11.75M-8.07M19.32M3.58M-21.58M-3.05M-1.74M-16.29M15.42M-4.69M9.91M2.33M568K2.09M-1.63M121K11.14M374K7.83M11K950K14K-3.17K-531.34K
Change in Receivables-4.38M664K69.22M-70.31M998K-747K5K32.37M-28.19M26.6M6.75M-13.33M-13.83M3.5M-6.93M5.07M-2.88M2.33M-6.03M04.15M-4.8M000000000
Change in Inventory785K212K1.05M3.3M-5.29M1.91M000-12.44M623K-92K8.79M19.91M000000000169K0000000
Change in Payables4.89M3.14M-8.12M-4.65M-136K760K-2.55M109K963K-6.35M-3.01M2.57M3.72M2.12M2.93M00000819K-309K000000000
Cash from Investing6.54M-21.01M-212.96M16.18M184.46M35.75M18.6M-68.06M-24.07M-16.11M-40.63M39.31M29.3M-66.06M-409.14M-23.24M-8.1M-8.65M5.07M-7.34M10.16M-13.09M-378K-2M-595K12.81M-44.3M-4.65M-3.82M465.1K-290.52K
Capital Expenditures-26.26M-16.69M-148.67M-189K-5.73M-21.09M-13.98M-183K-34K-2K-1.23M-19.51M-42.85M-25.74M-178.53M-14.87M-8.28M-9.69M-2.17M-223K-1.21M-75K-81K-83K-78K-3.77M-2.48M-890K-374K-92.06K-72.27K
CapEx % of Revenue9.61%5.85%121.55%0.15%9.68%23.95%46.94%1.63%0.03%0%0.8%15.6%32.74%19.71%71.2%8.63%6.28%14.39%4.5%0.42%3.47%0.38%1.89%11.99%181.4%15.32%4343.86%729.51%97.91%21.32%2.23%
Acquisitions01.23M-87.68M-9.41M0-33.25M13.78M0-7M-31.51M-1.23M19.5M42.75M25.06M-150M14.68M002.14M-5.2M-16K-5.8M-198K000000072.27K
Investments-------------------------------
Other Investing28.39M-12.2M-14M6.74M28.4M-1.66M-14.19M-4.42M-24.03M-4M-18.77M-19.5M-42.75M-25.06M-408.52M-14.68M0-8.65M-2.14M-3.76M-353K-445K-5K30.8M-517K-3M-2.14M-3.76M-3.42M489.13K1.09M
Cash from Financing-6.85M-22.73M97.56M58.63M-166.14M59.74M109.21M33.92M-4.61M700K-1.11M-28.6M-25.7M-25.55M211.26M176.34M13.96M-4.01M142K10.38M1.2M19.66M-305K6.43M-2.05M23.16M77.32M40.91M13.52M2.32M1.21M
Debt Issued (Net)1M-22.09M103.46M-67.7M-120M65M110.44M000000000000000000-221K001.4M-1.45M552.5K
Equity Issued (Net)030K-20.29M79.11M-41.74M-4.01M-4M33.84M-4.86M-45K-82K00-7.93M192.23M175.23M0-1.11M05.01M1.48M19.84M00020.12M39.97M34.27M12.22M3.2M335K
Dividends Paid000-1.4M-2.8M-1.45M-1.38M0000-25.43M-25.04M-18.63M00000000000000000
Share Repurchases00-20.29M0-50.99M-4.01M-4M0-4.86M-45K-82K00-7.93M-26.73M00-1.11M0000000000000
Other Financing-7.85M-675K14.38M48.62M-1.6M202K4.15M79K257K745K-1.03M-3.17M-661K1.01M19.03M-364K13.96M-2.9M142K5.37M-277K12.73M-305K6.43M-2.05M3.26M37.35M6.63M-99K572.75K318.81K
Net Change in Cash35.15M32.84M-66.21M52.3M-21.57M108.81M108.19M-36.45M-7.79M9.06M-7.68M757K7.78M-95.12M-92.93M212.22M50.78M3.46M7.81M423K17.72M3.57M-4.64M516K-7.07M23.29M-1.68M30.12M6.14M1.07M-612.36K
Free Cash Flow9.17M58.55M-112.55M-28.7M-43.07M-7.76M-33.6M-6.91M20.84M24.48M32.83M-29.46M-38.67M-29.25M-73.58M44.24M36.64M6.43M432K-2.84M5.15M-3.06M-4.04M-3.99M-4.5M-16.34M-37.17M-7.03M-3.93M-1.8M-1.6M
FCF Margin %3.35%20.53%-92.01%-22.94%-72.72%-8.82%-112.82%-61.45%15.85%37.42%21.5%-23.56%-29.55%-22.4%-29.35%25.68%27.79%9.54%0.9%-5.4%14.79%-15.66%-94.3%-577.02%-10469.77%-66.31%-65210.53%-5758.2%-1029.58%-417.24%-49.39%
FCF Growth %-67.45%152.02%-292.21%33.37%-454.64%76.89%-386.17%-133.16%-14.84%-25.45%211.44%23.82%-32.23%60.25%-266.32%20.74%470.18%1387.5%115.22%-155.13%268.03%24.13%-1.18%11.31%72.44%56.05%-429.11%-78.62%-118.31%-12.57%-184.17%
FCF per Share0.090.60-1.13-0.31-0.47-0.08-0.58-0.140.420.480.66-0.60-0.77-0.61-1.551.101.040.210.01-0.100.19-0.12-0.20-0.20-0.23-0.85-2.27-0.65-0.20-0.09-0.08
FCF Conversion (FCF/Net Income)-0.51x3.47x-1.39x-0.34x0.30x0.09x-0.18x0.13x-0.20x1.10x-0.63x0.06x-0.06x0.06x1.77x2.96x1.32x-1.43x-0.19x0.17x-1.16x0.48x0.71x0.72x0.35x0.56x0.89x0.75x0.58x0.60x-3.58x
Interest Paid08.3M5.06M2.51M7.23M7.34M0000000000000000000000000
Taxes Paid001.05M831K384K25K0000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Earnings quality severely distorted

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Cash Flow Decoupled from Accounting Losses

The ratio of operating cash flow to net income is wildly erratic, swinging from -295x to 83x, indicating that reported losses are a poor proxy for actual cash generation and that cash inflows are likely driven by non-recurring settlement receipts.

This extreme volatility in the OCF/NI ratio, as seen in the -295.83 figure for 2024Q1 and the 83.06 for 2026Q2, suggests that cash generation is dominated by the timing of large, discrete cash events rather than sustainable profitability. The consistent non-cash add-backs like depreciation and amortization help bridge the gap from negative net income to positive operating cash flow in many quarters, but this does not signal operational health.

Episodic FCF Masked by Settlement Timing

Free cash flow margins are completely unmoored from profitability, ranging from -48.2% to 93.5% over ten quarters, which demonstrates that FCF is an episodic event driven by settlement cash receipts rather than a sustainable operational trajectory.

The stark disconnect is clear: the peak FCF margin of 93.5% in 2025Q2 occurred during a net loss, while the strongest net income quarter of 2025Q1 produced a near-zero 0.3% FCF margin. This pattern implies that FCF timing is a critical factor in assessing the company's liquidity, but it provides no reliable signal about the future sustainability of cash flows absent a visible pipeline of future settlements.

Capital Spending as Opportunistic, Not Operational

CapEx intensity is highly variable, with a CapEx-to-Revenue ratio ranging from 1.1% to 29.0%, indicating that capital deployment is episodic and tied to specific acquisitions or investments rather than steady, predictable operational maintenance or growth.

The extreme volatility, such as the massive negative CapEx (likely an acquisition) of $142.9M in 2024Q2 followed by quarters of minimal spending, points to a business model that does not require continuous, significant capital investment to generate revenue. The lack of a consistent relationship between depreciation & amortization and CapEx further suggests that reported D&A may not be a reliable proxy for true capital replacement needs in this patent licensing model.

Settlement Timing Drives All Cash Swings

Working capital changes have been massive and unpredictable, with quarterly swings exceeding $50 million, indicating that cash flows are dominated by the lumpy timing of settlement-related receivables and payables rather than efficient operational cycle management.

The $48.5M source in 2025Q2 and the $44.4M use in 2025Q1 exemplify this extreme volatility. These flows almost certainly result from large, non-recurring settlement cash receipts and associated legal fee payments, which completely obscure any underlying trends in the operational efficiency of the business. Investors should view reported operating cash flow with significant skepticism, as it may primarily reflect settlement timing in any given quarter.

Cumulative Losses vs. Positive Cash Generation

Over the last ten quarters, the company has reported cumulative net losses while generating positive cumulative operating cash flow, revealing a profound divergence where the cash reality appears stronger than the earnings reality but is entirely dependent on unpredictable settlement proceeds.

This cumulative gap highlights the fundamental flaw in using accrual-based net income to evaluate ACTG's financial health. The cash reality appears stronger, but it is driven by non-cash expenses and settlement proceeds. As reported in the financial statements, the positive cumulative operating cash flow is a result of these settlement-related inflows and the add-back of non-cash items like depreciation and amortization, masking the underlying unprofitability of the fixed cost structure.

Cash Flow Statement Obscures True Cost Structure

The cash flow statement obscures the true, unprofitable cost structure by adding back non-cash charges like depreciation and amortization, while the working capital swings related to settlements can create a misleading impression of operational cash generation strength in any given quarter.

For example, the $54.8M operating cash flow in 2024Q1 was driven almost entirely by a $54.8M positive working capital change, likely a settlement receipt, rather than operational performance. Furthermore, stock-based compensation, while a non-cash expense, represents a real dilutive cost to shareholders that is added back to calculate cash flow, potentially overstating the true economic cash generation. The capital expenditure line also obscures the nature of spending, as large negative figures likely represent acquisitions rather than organic investment, further complicating the assessment of reinvestment needs.

ACTG — Frequently Asked Questions

Quick answers to the most common questions about buying ACTG stock.

How much cash does Acacia Research Corporation (ACTG) generate from operations?

Acacia Research Corporation (ACTG) generated $75.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Acacia Research Corporation's free cash flow?

Acacia Research Corporation (ACTG) generated $58.5M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Acacia Research Corporation's capital expenditure (CapEx)?

Acacia Research Corporation (ACTG) spent $16.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.